Durvalumab, Cediranib ± Olaparib in Recurrent Ovarian Cancer
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
In a groundbreaking phase II proof-of-concept clinical trial published recently in Nature Communications, researchers led by Tabata, Huang, and Giudice ...
In recent years, the challenge of overcoming drug resistance in cancer therapies has become a focal point of medical research. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine